Diseased skin models in the hairless guinea pig: In vivo percutaneous absorption

Dermatology

Volumn 180, Issue 1, 1990, Pages 8-12

  Moon, K C ^a,b   Wester, R C ^b   Muibach, H I ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Korea University College of Medicine   (South Korea)

Author keywords

Benzoic acid; Diseased skin models; Guinea pig; Hydrocortisone; Percutaneous absorption

Indexed keywords

BENZOIC ACID; HYDROCORTISONE; RADIOISOTOPE;

ANIMAL; ANIMAL CELL; ARTICLE; DISEASE MODEL; GUINEA PIG; MAMMAL; NONHUMAN; PRIORITY JOURNAL; SKIN ABSORPTION; SKIN DISEASE; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANIMAL; BENZOATES; BENZOIC ACID; DISEASE MODELS, ANIMAL; FEMALE; GUINEA PIGS; HYDROCORTISONE; INJECTIONS, INTRAPERITONEAL; SKIN ABSORPTION; SKIN DISEASES; SODIUM DODECYL SULFATE;

EID: 0025124469     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000247977     Document Type: Article

References (43)

1. Bucks DA. Maibach HI. Guy RH: Mass balance and dose accountability in percutaneous absorption studies: Development of a non- occlusive application system. Pharmaceutical Res 1988:5:313-315.
2. Feldmann, R.I, Maibach, HI: Percutaneous absorption of steroid in man. J Invest Dermatol 1969:52:89-94.
3. Andersen KE. Maibach HI. Anjo MD: The guinca-pig:An animal model for human skin absorption of hydrocortisone, testosterone and benzoic acid? Br J Dermatol 1980:102:447-453.
4. Bronaugh RE. Stewart RT: Methods for in vitro percutaneous absorption studies. V. Permeation through damaged skin. J Pharm Sci 1985:74:1062-1066.
5. Wurster DE: Some physical-chemical factors influencing percuta- neousabsorption from dermatologieals. Cun Probl Dermatol 1978: 7:156-171.
6. Barry BW: Dermatological formulations: Percutaneous absorption: in Swarbrick J (ed): Drugs and Pharmaceutical Sciences. New York. Dekker. 1983. vol 18. pp 127-233.
7. Wester RC. Maibach HI: Cutaneous pharmacokinetics: 10 steps to percutaneous absorption. DrugMetab Rev 1983:14:169-205.
8. Feldmann, RJ, Maibach, HI: Penetration of14C-hydrocortisone through normal skin: The effect of stripping and occlusion. Arch Dermatol 1965:91:661-666.
9. Foreman, MI, Clanachan, I, Kelly, IP: The diffusion of nandrolone through occluded and non-occluded human skin. J Pharm Pharmacol 1978:30:152-157.
10. Wester RC. Maibach HI: Dermatopharmacokinctics: A dead membrane or a complex multifunctional viable process?: in Bridges JW. Chasseaud LF (eds): Progress in Drug Metabolism. London, Taylor & Francis. 1986. vol 9. pp 95-109.
11. Rougier, A, Lotte, C, Dupuis, D: An original predictive method for in vivo percutaneous absorption studies. J Soc Cosmet Chem 1987; 38:397-417.
12. Ozawa, Y, Yamahira, T, Nadai, T: A new technique forili vivo percutaneous absorption. Chem Pharm Bull (Tokyo) 1987:35:2114-2118.
13. Malkinson FD, Ferguson EH: Percutaneous absorption of hydrocortisone-4-14C in two human subjects. J Invest Dermatol 1955:25: 281-283.
14. Bartek MJ. Labudde JA. Maibach HI: Skin permeability in vivo: Comparison in rat, rabbit, pig and man. J Invest Dermatol 1972:58: 114-123.
15. Feldmann R.J. Maibach HI: Regional variation in percutaneous penetration of14C cortisol in man. J Invest Dermatol 1967:48: 181-183.
16. Wester RC. Noonan PK. Maibach HI: Variation in percutaneous absorption of testosterone in the rhesus monkey due to anatomic site of application and frequency of application. Arch Dermatol Res 1980:267:229-235.
17. Wester RC. Maibach HI: Relationship of topical dose and percutaneous absorption-rhesus monkey and man. J Invest Dermatol 1976:67:518-520.
18. Ponec M: Penetration of corticosteroids through the skin in relation to the vehicle. Dermatologica 1976:152 (suppl 1):37-46.
19. Idson B: Vehicle effects in percutaneous absorption. Drug Metab Rev 1983:14:207-222.
20. Washitake, M, Yajima, T, Anmo, T, et al: Studies on percutaneous absorption of drugs. III. Percutaneous absorption of drugs through damaged skin. Chem Pharm Bull (Tokyo) 1973:21:2444-2451.
21. Osamura H. Jimbo Y. Ishihara M: Skin penetration of nicotinic acid, methyl nicotinate and butyl nicotinate in the guinea pig-comparison of in vivo and excised skin and the effects of four dermatologie conditions. J Dermatol (Tokyo) 1984;11:471-481.
22. Scott RC. Walker M. Dugard PH: In vitro percutaneous absorption experiments: A technique for the production of intact epidermal membranes from rat skin. J Soc Cosmet Chem 1986:37:35-41.
23. Sinha ALW. Shaw SR. Weber DJ: Percutaneous absorption and excretion of tritium-labeled diflorasone diacetate, a new corticosteroid in the rat. monkey and man. J Invest Dermatol 1978:71: 372-377.
24. Behl, CR, Flynn, GL, Barrett, M, et al: Permeability of the thermally damaged skin.II.Immediate influences of branding at 60 C on hairless mouse skin permeability. Burns 1981;7:389-399.
25. Lamaud, E, Schalla, W: Influence of UV irradiation on penetration of hydrocortisone. In vivo study in hairless rat skin. Br J Dermatol 1984:111 (suppl 27): 152-157.
26. Solomon AE. Lowe NJ: Percutaneous absorption in experimental epidermal disease. BrJ Dermatol 1979:100:717-722.
27. Roberts, MS, Anderson, RA, Swarbrick, J: Permeability of human epidermis to phenolic compounds. J Pharm Pharmacol 1977:29: 677-683.
28. Malten KE. Thiele FAJ: Evaluation of skin damage. II. Water loss and carbon dioxide release measurements related toskin resistance measurements. BrJ Dermatol 1973:89:565-569.
29. Wester RC. Bucks DAW. Maibach HI: In vivo percutaneous absorption of hydrocortisone in psoriatic patients and normal volunteers. J Am Acad Dermatol 1983:8:645-647.
30. Grice, KA, Sattar, H, Baker, H: The cutaneous barrier to salts and water in psoriasis and in normal skin. Br J Dermatol 1973:88: 459-463.
31. Bronaugh RL. Weingarten DP. Lowe NJ: Differential rates of percutaneous absorption through the eczematous and normal skin of a monkey. J Invest Dermatol 1986;87:451-453.
32. Lambrey B. Schalla W. Kail N. et al: Influence of an essential fatty acid deficient diet on absorption of topical hydrocortisone in the rat. Br J Dermatol 1987;117:607-615.
33. Turpeinen M: Influence of age and severity of demiatitison the percutaneous absorption of hydrocortisone in children. Br J Dermatol 1988;118:517-522.
34. Patrick E. Burkhalter A. Maibach HI: Mouse ear assays as models for studying mechanisms of chemically induced irritation: in Mai-bach HI. Lowe NJ (eds): Models Dermatol. Basel. Karger. 1987. vol 3. pp 86-92.
35. Van Der Valk, PGM, Nater, JP, Bleumink, E: Skin irritancy of surfactants as assessed by water vapor loss measurements. J Invest Dermatol 1984;82:291-293.
36. Patrick E. Burkhalter A. Maibach HI: Recent investigations of mechanism of chemically induced skin irritation in laboratory mice. J Invest Dermatol 1987;88:24s-31s.
37. Scheuplein R.L Ross L: Effects of surfactants and solvents on the permeability of epidermis. J Soc Cosmet Chem 1970;21:853-873.
38. Elias PM: Epidermal lipids, barrier function and desquamation. J Invest Dermatol 1983:80:44s-49s.
39. Smith WP. Christensen MS. Nacht S. et al: Effect of lipids on the aggregation and permeability of human stratum corneum. J Invest Dermatol 1982:78:7-11.
40. Berenson GS. Burch GE: Studiesof diffusion of water through dead human skin: The effect of different environmental states and of chemical alterations of the epidermis. Am J TropMed Hyg 1951:31: 842-853.
41. Mali JEH: The transport of water through the human epidermis. J Invest Dermatol 1956:27:451-469.
42. Onken HD. Moyer CA: The water barrier in human epidermis. Arch Dermatol 1963:87:584-590.
43. Matoltsy AG. Downes AM. Sweeney TM: Studiesof the epidermal water barrier. II. Investigation of the chemical nature of the water barrier. J Invest Dermatol 1968:50:19-26.